Reducing the adverse effects of immune evasion and enhancing host immunity are critical directions for vaccine development and medicine research and unraveling the immune evasion mechanisms and pathogenesis of Mhp will pave the way for the development of new therapeutics for MPS. The gene discussed is CACNA1A; the disease is mucopolysaccharidosis.